Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-26 @ 1:35 AM
Study NCT ID:
NCT00879333
Status:
COMPLETED
Last Update Posted:
2015-11-03
First Post:
2009-04-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-08
First Submit QC Date:
None
Study First Post Date:
2009-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-28
Results First Submit QC Date:
None
Results First Post Date:
2015-04-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-08
Last Update Post Date:
2015-11-03
Last Update Post Date Type:
ESTIMATED